Niagen Bioscience, Inc. (NAGE)
The company now
Niagen Bioscience, Inc. is classed by the SEC under Medicinal Chemicals & Botanical Products (industry code 2833), based in Los Angeles, CA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $129 million and a profit of $17 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
Where the revenue comes from
fiscal 2025, as filedRevenue by line of business, fiscal 2025
| Line of business | Fiscal 2025 | Fiscal 2024 | Share of revenue |
|---|---|---|---|
| Consumer Products | $97.7M | $76.8M | 75.5% |
| Ingredients | $28.7M | $19.8M | 22.2% |
| Analytical Reference Standards and Services | $3.1M | $3.0M | 2.4% |
As tagged in its annual report (Form 10-K, filed Mar 4, 2026 ↗), read from the SEC's financial statement data sets. The year before is the figure the record holds for the prior fiscal year.
The desk's written account of this company, its Past, Present and Future, is not on file yet.
How the company works
The desk has not read this company's annual report yet.
The record in brief
The desk has not written this company's report yet.